| Dr Sofia Alvarez, PSYD | |
|
117 Vip Dr Ste 310, Wexford, PA 15090-6936 | |
| (724) 934-3905 | |
| (724) 934-3906 |
| Full Name | Dr Sofia Alvarez |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 4 Years |
| Location | 117 Vip Dr Ste 310, Wexford, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043719081 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | PS019439 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New Directions Mental Health, Pc | 0345228318 | 61 |
News Archive
Weight-loss surgery has long been shown to improve or resolve diabetes, reduce heart attacks and stroke and produce significant weight loss, but the operation has generally been restricted by health insurers to people with severe obesity, which means about 75 to 100 pounds overweight or a body mass index (BMI) of 35 or higher.
Men with an elevated, genetically inherited risk for prostate cancer could be routinely identified with a simple blood or urine test, scientists at UC San Francisco and Kaiser Permanente Northern California have concluded, potentially paving the way to better or earlier diagnosis.
Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (Nasdaq: PRXL), today introduced unique product convergence between its DataLabs® EDC solution and ClinPhone® Randomization and Trial Supply Management (RTSM) technologies.
The study entitled "A phase II neoadjuvant sequential regimen of docetaxel followed by high-dose epirubicin in combination with cyclophosphamide administered concurrently with trastuzumab.
Avillion LLP, a co-developer of late-stage pharmaceutical assets, announces that the first patients have been dosed in the United States in a global Phase 3 clinical trial called "BFORE," which is designed to assess the effectiveness and safety of BOSULIF (bosutinib) as a first-line treatment for patients with chronic phase Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML). The first patient was dosed on July 22, 2014.
› Verified 3 days ago
| Entity Name | New Directions Mental Health, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215904800 PECOS PAC ID: 0345228318 Enrollment ID: O20040708000230 |
News Archive
Weight-loss surgery has long been shown to improve or resolve diabetes, reduce heart attacks and stroke and produce significant weight loss, but the operation has generally been restricted by health insurers to people with severe obesity, which means about 75 to 100 pounds overweight or a body mass index (BMI) of 35 or higher.
Men with an elevated, genetically inherited risk for prostate cancer could be routinely identified with a simple blood or urine test, scientists at UC San Francisco and Kaiser Permanente Northern California have concluded, potentially paving the way to better or earlier diagnosis.
Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (Nasdaq: PRXL), today introduced unique product convergence between its DataLabs® EDC solution and ClinPhone® Randomization and Trial Supply Management (RTSM) technologies.
The study entitled "A phase II neoadjuvant sequential regimen of docetaxel followed by high-dose epirubicin in combination with cyclophosphamide administered concurrently with trastuzumab.
Avillion LLP, a co-developer of late-stage pharmaceutical assets, announces that the first patients have been dosed in the United States in a global Phase 3 clinical trial called "BFORE," which is designed to assess the effectiveness and safety of BOSULIF (bosutinib) as a first-line treatment for patients with chronic phase Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML). The first patient was dosed on July 22, 2014.
› Verified 3 days ago
| Entity Name | New Directions Counseling Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548373541 PECOS PAC ID: 4183674393 Enrollment ID: O20050126000139 |
News Archive
Weight-loss surgery has long been shown to improve or resolve diabetes, reduce heart attacks and stroke and produce significant weight loss, but the operation has generally been restricted by health insurers to people with severe obesity, which means about 75 to 100 pounds overweight or a body mass index (BMI) of 35 or higher.
Men with an elevated, genetically inherited risk for prostate cancer could be routinely identified with a simple blood or urine test, scientists at UC San Francisco and Kaiser Permanente Northern California have concluded, potentially paving the way to better or earlier diagnosis.
Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (Nasdaq: PRXL), today introduced unique product convergence between its DataLabs® EDC solution and ClinPhone® Randomization and Trial Supply Management (RTSM) technologies.
The study entitled "A phase II neoadjuvant sequential regimen of docetaxel followed by high-dose epirubicin in combination with cyclophosphamide administered concurrently with trastuzumab.
Avillion LLP, a co-developer of late-stage pharmaceutical assets, announces that the first patients have been dosed in the United States in a global Phase 3 clinical trial called "BFORE," which is designed to assess the effectiveness and safety of BOSULIF (bosutinib) as a first-line treatment for patients with chronic phase Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML). The first patient was dosed on July 22, 2014.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sofia Alvarez, PSYD 5224 Natrona Way, Pittsburgh, PA 15201-2550 Ph: (609) 802-7324 | Dr Sofia Alvarez, PSYD 117 Vip Dr Ste 310, Wexford, PA 15090-6936 Ph: (724) 934-3905 |
News Archive
Weight-loss surgery has long been shown to improve or resolve diabetes, reduce heart attacks and stroke and produce significant weight loss, but the operation has generally been restricted by health insurers to people with severe obesity, which means about 75 to 100 pounds overweight or a body mass index (BMI) of 35 or higher.
Men with an elevated, genetically inherited risk for prostate cancer could be routinely identified with a simple blood or urine test, scientists at UC San Francisco and Kaiser Permanente Northern California have concluded, potentially paving the way to better or earlier diagnosis.
Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (Nasdaq: PRXL), today introduced unique product convergence between its DataLabs® EDC solution and ClinPhone® Randomization and Trial Supply Management (RTSM) technologies.
The study entitled "A phase II neoadjuvant sequential regimen of docetaxel followed by high-dose epirubicin in combination with cyclophosphamide administered concurrently with trastuzumab.
Avillion LLP, a co-developer of late-stage pharmaceutical assets, announces that the first patients have been dosed in the United States in a global Phase 3 clinical trial called "BFORE," which is designed to assess the effectiveness and safety of BOSULIF (bosutinib) as a first-line treatment for patients with chronic phase Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML). The first patient was dosed on July 22, 2014.
› Verified 3 days ago
Dr. Joe Martin Utay, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 12045 Perry Hwy, Wexford, PA 15090 Phone: 724-940-1090 Fax: 724-940-1030 | |
Dr. Annalisa Angelica Almendras, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 101 Bradford Rd Ste 212, Wexford, PA 15090 Phone: 412-253-7109 Fax: 412-253-7109 | |
Dr. Francis Richard Kush, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 117 Vip Dr Ste 310, Wexford, PA 15090 Phone: 724-934-3905 Fax: 724-934-3906 | |
Dr. Jason Braun, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 461 Fairmont Dr, Wexford, PA 15090 Phone: 727-251-2516 | |
Dr. Kathleen Marie Kocherzat, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 117 Vip Dr, Wexford, PA 15090 Phone: 412-494-8448 | |
Andrew Nocita, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 10475 Perry Hwy, Towne Center, Ste 300, Wexford, PA 15090 Phone: 724-759-7500 Fax: 724-759-7600 |